Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus.

Deas TS, Bennett CJ, Jones SA, Tilgner M, Ren P, Behr MJ, Stein DA, Iversen PL, Kramer LD, Bernard KA, Shi PY.

Antimicrob Agents Chemother. 2007 Jul;51(7):2470-82. Epub 2007 May 7.

2.

West Nile virus 5'-cap structure is formed by sequential guanine N-7 and ribose 2'-O methylations by nonstructural protein 5.

Ray D, Shah A, Tilgner M, Guo Y, Zhao Y, Dong H, Deas TS, Zhou Y, Li H, Shi PY.

J Virol. 2006 Sep;80(17):8362-70.

3.

High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery.

Puig-Basagoiti F, Deas TS, Ren P, Tilgner M, Ferguson DM, Shi PY.

Antimicrob Agents Chemother. 2005 Dec;49(12):4980-8.

4.

Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication.

Deas TS, Binduga-Gajewska I, Tilgner M, Ren P, Stein DA, Moulton HM, Iversen PL, Kauffman EB, Kramer LD, Shi PY.

J Virol. 2005 Apr;79(8):4599-609.

Supplemental Content

Support Center